Azacitidine and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported as a side effect among people who take Azacitidine (azacitidine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Venclexta, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Azacitidine. It is created by eHealthMe based on reports of 17,184 people who have side effects when taking Azacitidine from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,799 drugs and 2,209 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

17,184 people reported to have side effects when taking Azacitidine.
Among them, 20 people (0.12%) have Chronic obstructive pulmonary disease.

Could Azacitidine cause Chronic obstructive pulmonary disease?

Among these 20 people:

How long have people been on Azacitidine when they have Chronic obstructive pulmonary disease? *

  • < 1 month: 87.5 %
  • 1 - 6 months: 12.5 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Chronic obstructive pulmonary disease when taking Azacitidine? *

  • female: 40 %
  • male: 60 %

What is the age of people who have Chronic obstructive pulmonary disease when taking Azacitidine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Azacitidine? *

  1. Venclexta: 4 people, 20.00%
  2. Zofran: 3 people, 15.00%
  3. Paracetamol: 3 people, 15.00%
  4. Acetylsalicylic Acid: 2 people, 10.00%
  5. Escitalopram: 1 person, 5.00%
  6. Lorazepam: 1 person, 5.00%
  7. Lisinopril: 1 person, 5.00%
  8. Hydrocodone: 1 person, 5.00%
  9. Exjade: 1 person, 5.00%
  10. Coumadin: 1 person, 5.00%

What are other side effects people have besides Chronic obstructive pulmonary disease? *

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 20.00%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 15.00%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 15.00%
  4. Pneumonia: 3 people, 15.00%
  5. Acidosis (build-up of carbon dioxide in the blood): 2 people, 10.00%
  6. Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 2 people, 10.00%
  7. Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 2 people, 10.00%
  8. Herniated Nucleus Pulposus (Slipped Disk): 2 people, 10.00%
  9. Hypercapnia (too much smoke): 2 people, 10.00%
  10. Blood Gases Abnormal: 2 people, 10.00%

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 17 people, 85.00%
  2. Stable Angina (a constant chest pain): 3 people, 15.00%
  3. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 15.00%
  4. Joint Pain: 3 people, 15.00%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 15.00%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 10.00%
  7. Constipation: 2 people, 10.00%
  8. Prostatomegaly (enlargement of the prostate): 1 person, 5.00%
  9. Oxygen Saturation Decreased: 1 person, 5.00%
  10. Nausea (feeling of having an urge to vomit): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and have Chronic obstructive pulmonary disease?

- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azacitidine:

Chronic obstructive pulmonary disease treatments and more:

How severe was Chronic obstructive pulmonary disease and when was it recovered:

Expand to all the drugs that have ingredients of azacitidine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azacitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic obstructive pulmonary disease:

Browse all the conditions that are associated with Chronic obstructive pulmonary disease:


How the study uses the data?

The study uses data from the FDA. It is based on azacitidine (the active ingredients of Azacitidine) and Azacitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: